Video

Digital Economy: The digitisation of healthcare w/ Jackie Hunter

What unique challenges surround the application of digital technologies in healthcare and how do we overcome them?

In this latest Digital Economy podcast from The Economist, Intelligence Unit host Pete Swabey discusses these challenges with Prof. Jackie Hunter, CE Clinical and Strategic Partnerships at BenevolentAI, Professor Ann Blandford, deputy director for digital health at the UCL Institute of Healthcare Engineering and Elizabeth Sukkar, Managing Editor and Global Editorial lead for healthcare at The EIU.

There are arguably few applications of digital technology more worthwhile than human health, however integrating technologies into healthcare systems is uniquely complex. This podcast provides an introduction to some of the challenges that healthcare providers face in their pursuit of digital innovation, and explores some of the paths forward. This episode touches upon issues ranging from health literacy, to the sensitivity of health data and the need for trust and transparency.

More Posts

You Might Also Like

Blog
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
At BenevolentAI, we are on a mission to bring life-changing medicines to patients, and we are looking for collaborative, mission-driven people to join our tech, drug discovery and business operations teams in London, Cambridge and New York.
Oct 17, 2021
News
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
BenevolentAI’s AI-Drug Discovery platform uncovered a novel target not previously linked to ulcerative colitis and advanced candidate to preclinical studies.
Oct 14, 2021
Blog
Measuring bias: moving towards more inclusive health research outcomes #stateofai
Having shared our open-source Diversity Analysis Tool last year, we were tasked to investigate and demonstrate the lack of diversity in biomedical data as part of the State of AI Report 2021.
Oct 12, 2021
Blog
Expert-augmented computational drug discovery for rare diseases
Combining scientific expertise, computational tools and our AI-enhanced biomedical knowledge graph to successfully uncover a new drug combination for treating a rare brain cancer in children.
Sep 28, 2021
News
BenevolentAI appoints Dr John Orloff to its Board of Directors
Biopharmaceutical veteran Dr John Orloff joins the BenevolentAI Board as a Non-Executive Director as it scales the development of its leading AI-derived drug pipeline.
Sep 9, 2021
Blog
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021